Acrobiosystems Co.,Ltd. (SHE:301080)

China flag China · Delayed Price · Currency is CNY
43.63
-1.37 (-3.04%)
At close: Mar 9, 2026
5.72%
Market Cap 7.30B
Revenue (ttm) 794.52M
Net Income (ttm) 172.77M
Shares Out 167.40M
EPS (ttm) 1.03
PE Ratio 42.39
Forward PE 28.89
Dividend 0.57 (1.27%)
Ex-Dividend Date n/a
Volume 3,563,233
Average Volume 3,652,226
Open 44.29
Previous Close 45.00
Day's Range 43.01 - 44.50
52-Week Range 26.00 - 71.49
Beta 0.87
RSI 29.19
Earnings Date Apr 21, 2026

About Acrobiosystems

Acrobiosystems Co.,Ltd. engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and scientific research institutions. The company has a collaboration with Diagnostic Biochips Inc for neurological drug discovery and commercialization. The company was founded in 2010 and is based in Beijing, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2010
Employees 869
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301080
Full Company Profile

Financial Performance

In 2024, Acrobiosystems's revenue was 645.02 million, an increase of 18.65% compared to the previous year's 543.65 million. Earnings were 123.83 million, a decrease of -19.38%.

Financial Statements

News

There is no news available yet.